Intravenous push administration of anti-seizure medications
Authors:
Open Access
- 27 January 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 15, 1503025
Abstract
Intravenous push (IVP) administration of anti-seizure medications is becoming increasingly popular among emergency departments. IVP administration eliminates the need for compounding and preparation by the pharmacy department, as well as the need to gather infusion materials or set up a patient’s tubing and pump, all of which translate to faster drug administration. This is important given the time-sensitive nature of status epilepticus treatment. This review will discuss several anti-seizure medications, including phenytoin, fosphenytoin, valproic acid, levetiracetam, brivaracetam and lacosamide, for which evidence supports the safe and efficacious use of IV push administration.Keywords
This publication has 50 references indexed in Scilit:
- Evaluation of Time to Administration, Benzodiazepine Use, and Safety of Intravenous Push Levetiracetam in a Neuro-Spine Intensive Care UnitNeurocritical Care, 2021
- Safety and Tolerability of Rapid Administration Undiluted LevetiracetamNeurocritical Care, 2019
- Safety and Efficiency of Intravenous Push Lacosamide AdministrationNeurocritical Care, 2018
- Randomized trial of lacosamide versus fosphenytoin for nonconvulsive seizuresAnnals of Neurology, 2018
- The Role of Clinical Pharmacists in the Emergency DepartmentJournal of Medical Toxicology, 2017
- Timing is everything: Where status epilepticus treatment failsAnnals of Neurology, 2017
- Clinical Pharmacokinetic and Pharmacodynamic Profile of LacosamideClinical Pharmacokinetics, 2015
- Efficacy and Safety of Intravenous Valproate for Status Epilepticus: A Systematic ReviewCNS Drugs, 2014
- Guidelines for the Evaluation and Management of Status EpilepticusNeurocritical Care, 2012
- Cardiopulmonary arrest following intravenous phenytoin loadingThe American Journal of Emergency Medicine, 1988